Programme

Selection of confirmed speakers:

  • Matthias Barz, Leiden
  • Pol Besenius, Mainz
  • Giulio Caracciolo, Rom
  • Patrick Couvreur, Paris
  • Helena Florindo, Lisbon
  • Bruno de Geest, Ghent
  • Rainer Haag, Berlin
  • Kazunori Kataoka, Tokyo
  • Twan Lammers, Aachen
  • Katharina Landfester, Mainz
  • Leyuan Ma, Philadelphia
  • David Mooney, Boston
  • Lutz Nuhn, Würzburg
  • Till Opatz, Mainz
  • Anna Salvati, Groningen
  • Raymond Schiffelers, Utrecht
  • Ulrich Schubert, Jena
  • Daniel Siegwart, Dallas
  • Nicole Steinmetz, San Diego
  • Martina Stenzel, Sydney
  • Melodie Swartz, Chicago

Friday 24th January, 2025

TimeSpeakerInstitutionTitle of the presentation
09:30Stephan Grabbe, Speaker, CRC1066University Medical Center, MainzWelcome address
09:40Georg Krausch, President JGUJohannes Gutenberg University MainzWelcome address
09:50Clemens Hoch, Minsiter of ScienceMinister of Science and Health, Rheineland-PalatinateWelcome address
10:00Patrick CouvreurUniversity of Paris-SudAdvanced nanomedicines for cancer treatment
10:30Helena Florindoimed - Universidade de LisboaUnveiling Solid Tumor Microenvironment for revolutionary nano-immunotherapies
11:00Daniel SiegwartUniversity of Texas Southwestern Medical Centertba
11:30Katharina LandfesterMax-Planck Institute for Polymer Reaserch, MainzNanocapsules: From the synthesis to in vivo applications
12:00short talk, SFB1066

Johannes Gutenberg University, Mainz

12:15Lunch and Poster discussion
13:30Raymond SchiffelersUniversity Medical Center Utrechttba
14:00Anna SalvatiRijksuniversiteit Groningentba
14:30Giulio Caracciolo

Sapienza Universita di Roma

tba
15:00Lutz Nuhn

Julius-Maximilians-University, Wrzburg

Macromolecular Strategies of the CRC1066 for EnhancingÿImmunotherapy Responses
15:30short talk, SFB1066

Johannes Gutenberg University, Mainz

15:45Coffee break
16:15short talk, SFB1066

Johannes Gutenberg University, Mainz

16:30Bruno de GeestUniversiteit GentEngineering recombinant fusion proteins for marker-agonist targeted cancer immunotherapy
17:00Nicole Steinmetz

University of California San Diego (UCSD)

tba
17:30Kazunori KataokaKawasaki Institute of Industrial Promotion, TokyoEngineered Nanosystems and Nanoconjugates for Cancer Immunotherapy
18:00Pol Besenius, Mainz

Johannes Gutenberg University, Mainz

Supramolecular Glycoconjugate Vaccines.
18:30Get-together with fingerfood at the posters

Saturday, 25th January, 2025

TimeSpeakerInstitutionTitle of the presentation
08:30Rainer Haag

Freie University, Berlin

Dendritic Polysulfate Nanosytems for Tumor and Virus Targeting
09:00Ulrich Schubert

Friedrich-Schiller-University, Jena

POx-Lipids as next generation PEG-Lipids for LNP: From replacing PEG to potential degradability to solvent free-formulation processes
09:30Martina StenzelUNSW Sydneytba
10:00Till Opatz

Johannes Gutenberg University, Mainz

tba
10:30short talk, SFB1066

Johannes Gutenberg University, Mainz

10:45Coffee break
11:15Matthias BarzUniversiteit LeidenPolypept(o)ides in Cancer Immune Therapy: Research at the CRC 1066 and Beyond.
11:45Melody Swartz Pritzker School of Molecular Engineering, Chicagotba
12:15Leyuan Ma Penn Institute for Immunology, PhiladelphiaA synthetic booster vaccine for CAR T cell therapy
12:45David MooneyWyss Institute - Harvard Universitytba
13:15Twan LammersRWTH Aachentba
13:45Katharina Landfester, Co-Speaker, CRC1066Max-Planck Institute for Polymer Reaserch, MainzClosing of the Symposium
14:00Lunch and Farewell

Symposium Chair

Prof. Dr. Stephan Grabbe

Direktor Hautklinik der Universitätsmedizin

Sprecher SFB 1066

Johannes Gutenberg Universität Mainz